We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients should not stop any treatments without consulting their doctor or pharmacist.
Multi-million pound investment in the UK’s first-ever magnet materials refiner launches alongside Critical Minerals Strategy.
First published during the 2019 to 2022 Johnson Conservative government
Syri Ltd has been fined £51,000 and ordered to pay costs of £104,898 by Aylesbury Crown Court.
Bayer plc and GE Healthcare AS are recalling batches of Magnevist Solution for injection, 0.5mmol/ml, intravenous and Omniscan Solutions for injection 0.5 mmol/ml following a safety review of the gadolinium containing contrast media by the European Medicines Agency (EMA).
Magnox has made the content from its latest supply chain engagement webinar available.
Automotive supply chain companies are collaborating through the Niche Vehicle Network to deliver savings and environmental benefits.
Work to empty the Magnox Swarf Storage Silo has taken a significant step forward.
Changes to standards and technical documents updated by CEN that affect those carrying out chemical measurement in support of animal feed regulation
Changes to standards and technical documents updated by CEN that affect those carrying out chemical measurement in support of regulation
Many food supplements contain hidden pharmaceutical ingredients that could be causing serious health risks, according to research
Omniscan and intravenous Magnevist are now no longer authorised for use and a product recall of any existing unexpired stock is underway.
Magnox is committed to playing its part to support the country in the response to the coronavirus pandemic.
Caution in Use: Distribute to Hospital Pharmacy, Ward and Operating Theatre Level
Studies of cardiovascular risk don’t support prescribing changes.
Some batches of gentamicin sulphate active pharmaceutical ingredient (API) used to manufacture gentamicin may contain higher than expected levels of histamine, which is a residual from the manufacturing process. Monitor patients for signs of histamine-related adverse reactions.
Products containing doses equal to or greater than 1178mg/day of base glucosamine will now be considered to be medicines.
Aluminium can be leached from glass after contact with calcium gluconate solution, leading to a risk of exposure to aluminium. Accumulation of aluminium might have adverse effects on bone mineralisation and neurological development in children and those with renal impairment....
Changes to guidance documents on food supplements and the lists of minerals permitted to be added to foods.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Decisions made by MHRA following investigations into complaints about advertising for licensed medicines.
Following our latest review of medical device alerts, we have archived the ones listed below.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).